The Incidence of Congenital Undescended Testis Among Dutch Infants

Undescended Testis Clinical Trial

Official title:

The Incidence of Congenital Undescended Testis Among Dutch Infants in the Medical Centre Alkmaar

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT00264121
• Other study ID #: P05.0318L
• Status: Recruiting
• Phase: N/A
• First received: December 9, 2005
• Last updated: May 21, 2008
• Start date: June 2005
• Est. completion date: June 2008

Study information

• Verified date: May 2008
• Source: Medical Center Alkmaar
• Contact: K. Sijstermans, MD
• Phone: +31-72-5482998
• Email: k.sijstermans[@]mca.nl
• Is FDA regulated: No
• Health authority: Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to determine the incidence of congenital undescended testis of mature boys, at one year of age, born in the Medical Centre Alkmaar (MCA).

Description:

The position of the testes of mature boys will be registered at birth and boys with a high-scrotal, non-scrotal or dubious position of the testis/ testes will be followed up (till the age of one year).

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 3000
• Est. completion date: June 2008
• Accepts healthy volunteers: No
• Gender: Male
• Age group: N/A to 1 Year

Eligibility

Inclusion Criteria:

• mature newborns (>/= 37 weeks)

• born in the Medical Centre Alkmaar

Exclusion Criteria:

• premature newborns (< 37 weeks)

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Cryptorchidism
• Undescended Testis

Locations

Country	Name	City	State
Netherlands	Medical Center Alkmaar (MCA)	Alkmaar	Noord-Holland

Sponsors (1)

Lead Sponsor	Collaborator
Medical Center Alkmaar

Country where clinical trial is conducted

Netherlands,